Skip to main content
Caplight Logo









MedLumics

MedLumics

Private
MadridHealthcare & Life Scienceshttps://medlumics.com/

Last Round

VC Round

Jul 29, 2024

Total Funding Raised

$66.11M

Company Overview

MedLumics is a medical device company developing AblaView, an optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

cardiac ablationatrial fibrillationpulsed field ablationPFAoptical coherence reflectometryOCRelectrophysiologycatheter systembiophotonic technologycardiac arrhythmialesion assessmentmedical devicemedtechEP labclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedLumics Comparables

Compare MedLumics with similar companies based on industry and business-model similarity.

MedLumics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioFocus
85%
Kardium
80%
Adagio Medical
80%

MedLumics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 29, 2024
VC RoundFeb 13, 2024
Series EFeb 10, 2021
GrantMay 1, 2019
Series BMar 20, 2017
Series A
Dec 1, 2011

Key People

Founding team and executive leadership

James Greene

Chief Executive Officer

Executive Team

MedLumics Investors

Notable investors and investment history

MedLumics investors
InvestorRounds
Asabys PartnersVC Round, Series E
CDTI InnvierteSeries E
Seroba Life SciencesSeries B
Andera PartnersSeries E, Series B
European CommissionGrant
Ysios CapitalSeries B, Series A
Innogest CapitalSeries B, Series E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2021

    $22M round led by Asabys Partners and VI Partners.

  • May 1, 2019

    $2.76M grant from the European Commission

MedLumics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MedLumics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedLumics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range11
Year Founded2009
Last FundingJul 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?